Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anoop Kumar

Showing results (541-550 of 543) with videos related to

Pageof 55
Sort By:
You have reached the last page of results.This site can display upto 543 results.
The Journal of Pharmacology and Experimental Therapeutics|July 15, 2016
Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic PainWalter Kostich, Brian D Hamman, Yu-Wen Li, et al.
Journal of Medicinal Chemistry|March 8, 2022
Discovery of (<i>S</i>)-1-((2',6-Bis(difluoromethyl)-[2,4'-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine (BMS-986176/LX-9211): A Highly Selective, CNS Penetrable, and Orally Active Adaptor Protein-2 Associated Kinase 1 Inhibitor in Clinical Trials for the Treatment of Neuropathic PainGuanglin Luo, Ling Chen, Walter A Kostich, et al.
Journal of Medicinal Chemistry|October 14, 2025
Design, Synthesis, and T Cell Checkpoint Combination Potential Of First-In-Class DGKα/ζ Inhibitor BMS-986408Denise C Grünenfelder, Upender Velaparthi, Jayakumar S Warrier, et al.
Pageof 55

Showing results (541-550 of 543) with videos related to

Sort By:
Pageof 55
You have reached the last page of results.This site can display upto 543 results.
The Journal of Pharmacology and Experimental Therapeutics|July 15, 2016
Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic PainWalter Kostich, Brian D Hamman, Yu-Wen Li, et al.
Journal of Medicinal Chemistry|March 8, 2022
Discovery of (<i>S</i>)-1-((2',6-Bis(difluoromethyl)-[2,4'-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine (BMS-986176/LX-9211): A Highly Selective, CNS Penetrable, and Orally Active Adaptor Protein-2 Associated Kinase 1 Inhibitor in Clinical Trials for the Treatment of Neuropathic PainGuanglin Luo, Ling Chen, Walter A Kostich, et al.
Journal of Medicinal Chemistry|October 14, 2025
Design, Synthesis, and T Cell Checkpoint Combination Potential Of First-In-Class DGKα/ζ Inhibitor BMS-986408Denise C Grünenfelder, Upender Velaparthi, Jayakumar S Warrier, et al.
Pageof 55